I would forego it. You just know the FDA isn't goi

I would forego it. You just know the FDA isn't going to approve a protocol for phase 3 NASH based on the interim results and a loose protocol framework for phase 3 could be developed now with slight modifications based on the final trial results. So it might be two weeks difference between doing interim and setting up a protocol and finalizing a protocol after full trial results.